Sign In
Buy SAN
$12.47
+0.310 (+2.55%)
At Close: Jun 04, 2026
Should Value Investors Buy Banco Santander (SAN) Stock?
02:40pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Should Value Investors Buy Banco Santander (SAN) Stock?
11:19am, Wednesday, 18'th Jan 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Sanofi: Information concerning the total number of voting rights and shares – December 2022
07:44pm, Tuesday, 17'th Jan 2023 GlobeNewswire Inc.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Decembre 2022
07:44pm, Tuesday, 17'th Jan 2023 GlobeNewswire Inc.
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marc
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns than research
06:40pm, Saturday, 14'th Jan 2023 MarketWatch
Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But they already spend more on stock buybacks and dividends.
Press Release: Sanofi Ventures announces multi-year capital commitment from Sanofi, increasing evergreen fund to $750M
04:30pm, Wednesday, 11'th Jan 2023 GlobeNewswire Inc.
Sanofi Ventures announces multi-year capital commitment from Sanofi, increasing evergreen fund to $750M
Communiqué de presse: Sanofi Ventures annonce un engagement de capital pluriannuel de la part de Sanofi, qui portera à 750 millions de dollars le capital de son fonds evergreen
04:30pm, Wednesday, 11'th Jan 2023 GlobeNewswire Inc.
Sanofi Ventures annonce un engagement de capital pluriannuel de la part de Sanofi, qui portera à 750 millions de dollars le capital de son fonds evergreen
Should Value Investors Buy Itau Unibanco (ITUB) Stock?
02:40pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Communiqué de presse: La FDA accepte d’examiner la demande de licence pour le nirsevimab, première option de protection contre le VRS pour tous les nourrissons
07:00am, Thursday, 05'th Jan 2023 GlobeNewswire Inc.
La FDA accepte d’examiner la demande de licence pour le nirsevimab, première option de protection contre le VRS pour tous les nourrissons
Press Release: FDA accepts nirsevimab application as first protective option against RSV disease for all infants
07:00am, Thursday, 05'th Jan 2023 GlobeNewswire Inc.
FDA accepts nirsevimab application as first protective option against RSV disease for all infants
Santander and Global Payments Team on Commercial Bank Card
05:13pm, Wednesday, 04'th Jan 2023
Santander Bank said it's working with Global Payments on a card offering for corporate clients. In a LinkedIn post on Wednesday (Jan. 4), Santander said that starting in early 2023, its U.S. commer
Communiqué de presse: Mise en ligne du document «Q4 2022 Memorandum for modelling purposes»
06:30am, Wednesday, 04'th Jan 2023 GlobeNewswire Inc.
Mise en ligne du document «Q4 2022 Memorandum for modelling purposes»
Press Release: Availability of the Q4 2022 Memorandum for modelling purposes
06:30am, Wednesday, 04'th Jan 2023 GlobeNewswire Inc.
Availability of the Q4 Memorandum for modelling purposes
Can XRP (Ripple) Reach $5 in 2023?
01:21pm, Wednesday, 28'th Dec 2022 The Motley Fool
As expected, the international payment token never crossed the $5 line in 2022. Next year may be a different story.
Press Release: Positive Dupixent® (dupilumab) Phase 3 results in adults and adolescents with eosinophilic esophagitis published in the New England Journal of Medicine
10:30pm, Wednesday, 21'st Dec 2022 GlobeNewswire Inc.
Positive Dupixent® (dupilumab) Phase 3 results in adults and adolescents with eosinophilic esophagitis published in the New England Journal of Medicine
